6A, avenue des Hauts-Fourneaux L-4365 Esch-sur-Alzette

Collaboration between OrganoTherapeutics and Neurolixis

OrganoTherapeutics and Neurolixis are happy to announce the conclusion of a collaboration agreement.

Neurolixis and OrganoTherapeutics share the aim to discovery and development of novel drugs for the treatment of Parkinson’s disease. This new collaboration with focus on the further development of neuroprotective compounds.